Evidence map›Paper›PMID 41971394›Full record

Trial reportInfection and drug resistance2026

Vonoprazan-Amoxicillin Dual Therapy with or Without

Ding-Ni Qu, Ze-Xuan Ji, Jun-Qi Zhang, Xiao-Yong Wang

Abstract readCase ReportsClinical Trial
PubMed Full text at PMC Publisher
In one paragraph

Trial report in Infection and drug resistance, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Ding-Ni Qu *Department of Gastroenterology, the Second People's Hospital of Changzhou, the Third Affiliated Hospital of Nanjing Medical University, Changzhou, Jiangsu Province, People's Republic of China.ORCID 0009-0006-4375-295X
Ze-Xuan Ji *Department of Gastroenterology, the Second People's Hospital of Changzhou, the Third Affiliated Hospital of Nanjing Medical University, Changzhou, Jiangsu Province, People's Republic of China.ORCID 0009-0005-0129-9571
Jun-Qi ZhangDepartment of Pathology, the Second People's Hospital of Changzhou, the Third Affiliated Hospital of Nanjing Medical University, Changzhou, Jiangsu Province, People's Republic of China.ORCID 0009-0006-7968-758X
Xiao-Yong WangDepartment of Gastroenterology, the Second People's Hospital of Changzhou, the Third Affiliated Hospital of Nanjing Medical University, Changzhou, Jiangsu Province, People's Republic of China.ORCID 0000-0001-8401-4888

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Whether the incorporation of Methods: In a single-center, randomized controlled trial, 190 adults with previous Results: Based on intention-to-treat analysis, Conclusion: Supplementing vonoprazan-amoxicillin dual therapy with Trial Registration: Chinese Clinical Trial Registry No. ChiCTR2300075382, September 4, 2023.

Indexed as

amoxicillinHelicobacter pylorirescue treatmentSaccharomyces boulardiivonoprazan

Identifiers

PMID41971394
PMCPMC13069978

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.